GlassScriptPhysician profile
Juan I Rivera
NPI 1275521023
$4,713.92
in general payments reported to CMS, 2019-2025
50 companies · $898 in 2025
The $898 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $820 · 2021: $736 · 2022: $908 · 2023: $457 · 2024: $571 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $731.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $509.76 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Amgen INC. | $480.13 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $403.79 | 2019-2024 | Mounjaro, Jardiance |
| Abbott Laboratories | $271.55 | 2020-2025 | Mitraclip, Freestyle Libre 3 |
| Boston Scientific Corporation | $260.20 | 2020-2025 | Watchman Flx, Intracept |
| Corcept Therapeutics | $137.97 | 2024-2025 | Korlym |
| Esperion Therapeutics, INC. | $136.06 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $115.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $113.03 | 2025 | Rosa |
| Pfizer INC. | $107.80 | 2019-2025 | |
| Radius Health, INC. | $88.43 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $87.86 | 2023-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $84.28 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Grt US Holding, INC. | $78.07 | 2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.